Sanofi and the FDA announced in late August, the approval of a new drug used to treat type 1 Gaucher disease. Eliglustat, or Cerdelga, is approved for the long-term treatment of the condition. Patients with type 1 Gaucher disease have a certain drug-metabolizing enzyme genotype, and this drug is designed to partially inhibit the production of the enzyme that makes glucocerebroside. [click to continue…]
In mid-August, the FDA and Merck announced a new medication approved as an insomnia treatment. Suvorexant is the first drug in its class that’s FDA approved. It is an orexin-receptor antagonist designed to help orexins regulate the sleep-wake cycle.
The FDA has recommended this medication be classified as a Schedule IV controlled substance. The drug will be marketed under the name Belsomra, by the end of the year or early in 2015. Before it can reach the market, the Drug Enforcement Administration, or DEA, must finalize the controlled substance scheduling process. [click to continue…]
The FDA has recently announced the approval of a new drug used to treat relapsing multiple sclerosis. Manufacturer Biogen Idec Inc. announced their peg interferon beta-1a injection, known as Plegridy, received approval as a treatment option for relapsing forms of MS.
By attaching a polyethylene glycol molecule to the interferon beta-1a, it extends the medication’s half life, thus allowing patients to go longer between doses. Their product has a dosing schedule of once every two weeks, while the other two interferon beta-1a products on the market must be administered one to three times a week. [click to continue…]
While most people know October as National Breast Cancer Awareness Month, few also know it is Healthy Lung Month. As a pharmacist, you can help your patients learn more about how to keep their lungs healthy and strong, providing extra education throughout October. [click to continue…]
Recently, the Missouri Department of Mental Health approved pharmacists to step into the role of psychiatric care provider. The decision has created a more efficient community treatment team.
Since community psychiatry involves reaching out to people wherever you find them (at home, in restaurants, even under bridges) to provide care and support, it is difficult to find psychiatrists who want to practice community psychiatry. As such, this allows a pharmacist to step into the role where a psychiatrist is difficult to find. [click to continue…]
Clinical pharmacist Candis Morello serves as the director of San Diego Department of Veterans Affairs (VA) Diabetes Intense Medical Management (DIMM) clinic. With her counseling, veterans with a history of type II diabetes are learning how to improve their condition. [click to continue…]